Deep sedation with propofol by pediatric intensive care physician during magnetic resonance imaging procedures: a prospective experience.

10.5580/24f7 ◽  
2010 ◽  
Vol 12 (1) ◽  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Intensive Care ◽  
Magnetic Resonance ◽  
Deep Sedation ◽  
Pediatric Intensive Care ◽  
Care Physician ◽  
Imaging Procedures ◽  
Resonance Imaging ◽  
Intensive Care Physician

Description and Contribution of Brain Magnetic Resonance Imaging in Nontraumatic Critically Ill Children

2016 ◽  
Vol 31 (14) ◽  
pp. 1584-1590 ◽  
Author(s):  
Guillaume Mortamet ◽  
Manoelle Kossorotoff ◽  
Amandine Baptiste ◽  
Nathalie Boddaert ◽  
Martin Castelle ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Intensive Care Unit ◽  
Intensive Care ◽  
Magnetic Resonance ◽  
Pediatric Intensive Care Unit ◽  
Brain Mri ◽  
Brain Magnetic Resonance Imaging ◽  
Pediatric Intensive Care ◽  
Critically Ill Children ◽  
Resonance Imaging

Background: The authors aimed to collect all brain magnetic resonance imaging (MRI) performed in critically ill children in the authors’ medical pediatric intensive care unit over a 2-year period (2012-2013) to (1) describe the findings and (2) assess its contribution on practical patient care. Methods: This is a single-center and retrospective study. All children without traumatic brain injury who underwent a brain MRI during pediatric intensive care unit stays were included. To assess the exam’s contribution, the patient’s medical condition at the time of the MRI exam was blindly and separately exposed to a pediatric neurologist and a pediatric intensivist. Results: During the study period, 87 patients (7.5%) underwent a brain MRI. Median age was 4 months and 13 children (14.9%) died in pediatric intensive care unit. The most common final diagnosis was postanoxic encephalopathy. Brain MRI was abnormal in 68 patients (78.2%). No serious adverse event occurred during the transport. The neurologist and the intensivist considered brain MRI as indicated during pediatric intensive care unit stay in 65 (74.7%) and 68 patients (78.2%). They deemed that brain MRI had a diagnostic contribution in 76 (87.4%) and 60 (69.0%) patients, respectively. A therapeutic change consecutive to MRI findings occurred in 19 patients (21.8%) and MRI results were associated with a decision to withdraw life-sustaining treatment in 21 patients (24.1%). Conclusion: Brain MRI is one component of neuromonitoring, and this study suggests a substantial diagnostic contribution, although its therapeutic impact appears limited to specific diagnoses.

Comparison of single-shot nebuliser protocol between dexmedetomidine and ketamine in children undergoing magnetic resonance imaging

2021 ◽  
pp. 175045892110374
Author(s):  
K Geetha ◽  
Shibani Padhy ◽  
K Karishma
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Deep Sedation ◽  
Rapid Onset ◽  
Single Shot ◽  
Efficacy And Safety ◽  
Resonance Imaging ◽  
Sedation Scores ◽  
To Receive ◽  
Group D

Background Sedation for magnetic resonance imaging mandates deep sedation to ensure patient immobility. The nebulised route of drug delivery carries the advantage of good bioavailability and safety profile. We aimed to compare the efficacy and safety of nebulised dexmedetomidine and ketamine for sedation in children undergoing magnetic resonance imaging. Methods A total of 71 children, aged two to eight years scheduled for outpatient magnetic resonance imaging were randomly allocated to receive nebulised dexmedetomidine 2 μg/kg (group D) or nebulised ketamine 2 mg/kg (group K) 30min before magnetic resonance imaging. Results Nebulised dexmedetomidine (2 μg/kg) resulted in faster onset and significantly better sedation scores with rapid clear-headed recovery. Ketamine resulted in better venepuncture scores but was associated with more neuropsychological events at recovery. Conclusion Nebulised dexmedetomidine at 2 μg/kg provides rapid onset of satisfactory sedation, with good parental separation and a quicker and more clear-headed recovery, allowing for a smooth magnetic resonance imaging experience.

Cost and Safety of Pediatric Intensive Care Physician-Placed Broviac Catheters

2014 ◽  
Vol 15 (1) ◽  
pp. 71-76 ◽  
Author(s):  
Robert K. Fitzgerald ◽  
Jennifer C. Yu ◽  
Surender Rajasekaran ◽  
Scott E. Curtis ◽  
Daniel J. Robertson ◽  
...  
Keyword(s):  
Intensive Care ◽  
Pediatric Intensive Care ◽  
Care Physician ◽  
Intensive Care Physician

scholarly journals MALIGNANT HYPERTHERMIA IN A CHILD AFTER MAGNETIC RESONANCE IMAGING: A CASE REPORT

2020 ◽  
Vol 38 ◽  
Author(s):  
Carlos Gustavo de Almeida ◽  
José Colleti Junior
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Malignant Hyperthermia ◽  
Pediatric Intensive Care ◽  
Muscle Stiffness ◽  
Resonance Imaging ◽  
Fatal Disease ◽  
Laboratory Findings ◽  
Reduced Body ◽  
Diagnostic Hypothesis

ABSTRACT Objective: To report on a case of malignant hyperthermia in a child after a magnetic resonance imaging of the skull was performed using sevoflurane anesthesia. Case description: A 3-year-old boy admitted to the pediatric intensive care unit after presenting clinical and laboratory findings consistent with unspecified viral meningoencephalitis. While the patient was sedated, a magnetic resonance imaging of the skul was performed using propofol followed by the administration of sevoflurane through a laryngeal mask in order to continue anesthesia. Approximately three hours after the start of the procedure, the patient presented persistent tachycardia, tachypnea, generalized muscular stiffness and hyperthermia. With a diagnostic hypothesis of malignant hyperthermia, dantrolene was then administered, which immediately induced muscle stiffness, tachycardia, tachypnea and reduced body temperature. Comments: Malignant hyperthermia is a rare pharmacogenetic syndrome characterized by a severe hypermetabolic reaction after the administration of halogenated inhalational anesthetics or depolarizing muscle relaxants such as succinylcholine, or both. Although it is a potentially fatal disease, the rapid administration of continued doses dantrolene has drastically reduced the morbidity and mortality of the disease.

The role of magnetic resonance imaging in the diagnosis of brachial plexopathy in a COVID-19 patient

2020 ◽  
pp. 1-4
Keyword(s):  
Magnetic Resonance Imaging ◽  
Intensive Care ◽  
Magnetic Resonance ◽  
Brachial Plexus ◽  
Early Recognition ◽  
Brachial Plexopathy ◽  
Resonance Imaging ◽  
Intensive Care Admission ◽  
Mri Protocol

Severe COVID-19 infection can lead to acute respiratory distress syndrome (ARDS) requiring intensive care admission. Mechanically ventilated patients are commonly managed by being positioned in a prone ‘swimmer’s position’. However, this position can lead to a variety of potential complications not related to the illness, including stretching of the brachial plexus resulting in nerve damage. Brachial plexopathy is an important consideration in all patients stepped down from prolonged prone ventilation. This is to prevent possible long-term numbness and weakness in the affected arm which may require intensive physiotherapy. The role of magnetic resonance imaging is particularly useful in visualizing the brachial plexus and providing an accurate diagnosis. Early recognition and prompt imaging is recommended to reduce the incidence and severity of brachial plexopathy, particularly in the wake of a second COVID-19 wave. We report a case of brachial plexopathy in a 54-year-old male following intensive care admission and the relevant MRI protocol and findings which highlight this pathology.

Sign in / Sign up

Export Citation Format

Share Document